Toshimasa Yamauchi
Toshimasa Yamauchi publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology, on topics such as Adipokines, Inflammation, and Metabolic Diseases, Adipose Tissue and Metabolism and Diabetes Treatment and Management.
- World rank
- #82,307 of 7,710,434 ranked researchers
- Rank in Japan
- #492 of 383,136
- Works
- 499
- Citations
- 53k
- Citations per work
- 106.6
What does Toshimasa Yamauchi research?
Toshimasa Yamauchi's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else20140.3%
- Health Sciences19539.0%
- Medicine19539.0%
- Life Sciences10320.7%
- 1Molecular Biology15% of their works
- 2Endocrinology, Diabetes and Metabolism14% of their works
- 3Epidemiology11% of their works
- 4Physiology10% of their works
- 5Genetics6% of their works
- 6Surgery4% of their works
Research topics
- Adipokines, Inflammation, and Metabolic Diseases
- Adipose Tissue and Metabolism
- Diabetes Treatment and Management
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
- Genetic Associations and Epidemiology
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Toshimasa Yamauchi's research?
The keywords of their largest research topics: Insulin Resistance, Obesity, Cardiovascular Disease, Type 2 Diabetes, Inflammation, Metabolic Syndrome, Adipokines and Adipose Tissue.
- Glucose Metabolism
- Atherosclerosis
- Genetic Variation
- PPARs
- AMP-Activated Protein Kinase
- Cardiovascular Outcomes
- Glycemic Control
- Brown Adipose Tissue
- Adipose Tissue
- Metabolic Syndrome
- Type 2 Diabetes
- Obesity
- Insulin Resistance
- Cardiovascular Disease
- Inflammation
- Adipokines
- Diabetes
- Thermogenesis
- Insulin Therapy
- Glucose Control
- Metformin
- Peroxisome Proliferator-Activated Receptors
- Genome-Wide Association
- Continuous Glucose Monitoring
- Hypoglycemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Insulin Resistance2333 topics
- Obesity1763 topics
- Cardiovascular Disease1693 topics
- Type 2 Diabetes1472 topics
- Inflammation1452 topics
- Metabolic Syndrome1382 topics
- Adipokines1071 topic
- Adipose Tissue1071 topic
- Diabetes1003 topics
- Brown Adipose Tissue951 topic
- Thermogenesis951 topic
- Glycemic Control712 topics
- Insulin Therapy712 topics
- Cardiovascular Outcomes401 topic
- Glucose Control401 topic
- AMP-Activated Protein Kinase391 topic
- Metformin391 topic
- PPARs381 topic
- Peroxisome Proliferator-Activated Receptors381 topic
- Genetic Variation361 topic
- Genome-Wide Association361 topic
- Atherosclerosis311 topic
- Continuous Glucose Monitoring311 topic
- Glucose Metabolism311 topic
- Hypoglycemia311 topic
Where does Toshimasa Yamauchi work?
Toshimasa Yamauchi's main affiliation in the publication record is The University of Tokyo, Japan.
How many publications and citations does Toshimasa Yamauchi have?
OpenAlex counts 499 works and 53,218 citations for Toshimasa Yamauchi, an h-index of 90, ranking #82,307 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Toshimasa Yamauchi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.